Fattibilità della terapia telefonica per problemi di salute mentale comuni incorporati nelle cliniche per l'epilessia pediatrica

Fattibilità della terapia telefonica per problemi di salute mentale comuni incorporati nelle cliniche per l’epilessia pediatrica

Il trattamento della salute mentale e fisica dovrebbe essere fornito insieme ai bambini e ai giovani con epilessia. La formazione degli operatori sanitari (HCP) nei servizi per l’epilessia per fornire interventi di salute mentale è un modo importante per facilitare l’assistenza integrata. Tredici operatori sanitari sono stati formati sulla fornitura dell’intervento. Un pneumologo pediatrico ha determinato la gravità e il controllo dell’asma di ogni partecipante durante una visita clinica. Per ogni paziente sono stati generati un punteggio CASI e ACT / C-ACT.

determinare la fattibilità della valutazione e del trattamento psicologico forniti a distanza per le difficoltà di salute mentale forniti dagli operatori sanitari nelle cliniche pediatriche per l’epilessia con una formazione formale limitata in interventi psicologici. Abbiamo ipotizzato che sarebbe stato (i) possibile formare gli operatori sanitari per fornire l’intervento psicologico e (ii) che i partecipanti che ricevevano la terapia psicologica avrebbero riportato riduzioni dei sintomi di difficoltà di salute mentale tra cui ansia, depressione e difficoltà comportamentali e migliorato la qualità della vita .

Trentaquattro bambini e giovani con epilessia che presentavano sintomi alteranti di una difficoltà di salute mentale comune (ansia, depressione, comportamento dirompente e / o trauma) sono stati assegnati a ricevere 6 mesi di un intervento cognitivo comportamentale modulare fornito da un operatore sanitario con limitata esperienza di terapia psicologica formale.La competenza degli operatori sanitari è stata valutata in un processo a due fasi. Le misurazioni riferite dai genitori dei sintomi di salute mentale e della qualità della vita sono state completate al basale e dopo l’intervento. Sono stati utilizzati test t accoppiati per analizzare i cambiamenti nei sintomi nel tempo.

tutti i tredici operatori sanitari che hanno partecipato alla formazione sono stati considerati competenti nell’erogazione terapeutica entro la fine del periodo di formazione. Ventitré pazienti hanno completato le misure pre e post intervento e sono stati inclusi nell’analisi. Ci sono stati miglioramenti statisticamente significativi in: sintomi di problemi di salute mentale (p = 0,01; d di Cohen = 0,62), impatto totale dei problemi di salute mentale (p = 0,03; d di Cohen = 0,52), sintomi di ansia e depressione (p = 0,02; d = 0,57) e qualità della vita (p = 0,01; d di Cohen = 0,57).

un trattamento cognitivo comportamentale modulare fornito per telefono da operatori sanitari con esperienza limitata di terapia psicologica era fattibile ed efficace nel trattamento dei problemi di salute mentale nei bambini e nei giovani con epilessia. Anche la qualità della vita correlata alla salute è migliorata durante la durata del trattamento. È necessario uno studio randomizzato controllato (RCT) per dimostrare l’efficacia dell’intervento.

Migliori pratiche di prescrizione di antibiotici per infezioni respiratorie attraverso l’uso di set di ordini computerizzati e sessioni educative nelle cliniche pediatriche

 

I sistemi computerizzati di supporto alle decisioni cliniche (CDSS) hanno mostrato un’efficacia promettente nel migliorare la prescrizione ambulatoriale di antibiotici. Abbiamo sviluppato un intervento sotto forma di set di ordini EPIC (Verona, WI, USA) comprendenti percorsi di trattamento ambulatoriale per 3 infezioni respiratorie acute batteriche pediatriche (ARI) accoppiati a sessioni educative. Quattro cliniche pediatriche sono state randomizzate in bracci di intervento e di controllo durante periodi di studio pre e postimplementazione.

Nelle cliniche di intervento, l’istruzione è stata fornita tra i 2 periodi di studio e le serie di ordini EPIC sono diventate disponibili all’inizio del periodo postimplementazione. L’endpoint primario era la percentuale di prescrizione di antibiotici di prima linea e gli endpoint secondari includevano la durata dell’antibiotico e la modifica della prescrizione di antibiotici entro 14 giorni.
sono state incluse un totale di 2690 prescrizioni di antibiotici.

Durante la fase di pre-implementazione, non vi era alcuna differenza nella prescrizione di antibiotici di prima linea o nella durata dell’antibiotico tra i studiare le armi. Dopo l’implementazione, le cliniche di intervento avevano una percentuale più alta di prescrizione di antibiotici di prima linea e una durata dell’antibiotico più breve ispetto a le cliniche di controllo. La percentuale di antibiotici modificati era piccola in tutte le cliniche (1,1% -1,6%) e non differiva prima e dopo l’intervento.

un CDSS computerizzato che coinvolge percorsi di trattamento sotto forma di set di ordini accoppiati a sessioni educative è stato associato a una percentuale più alta di prescrizione di antibiotici di prima linea e una durata più breve dell’antibiotico per il trattamento ambulatoriale delle ARI batteriche pediatriche. Metodi I bambini di età compresa tra 5 e 18 anni con una diagnosi medica di asma persistente sono stati reclutati da un centro di assistenza terziaria.

Fattibilità della terapia telefonica per problemi di salute mentale comuni incorporati nelle cliniche per l'epilessia pediatrica

La proporzione di casi di malattie infettive, i suoi fattori associati e l’appropriatezza della prescrizione di antimicrobici tra i pazienti pediatrici rifugiati Rohingya nelle cliniche mobili IMARET

 

I Rohingya sono fuggiti dalla loro casa per sfuggire alla persecuzione etnica. A causa del loro status di rifugiati, hanno difficoltà ad accedere all’assistenza sanitaria che porta a mortalità e morbilità evitabili. Si dice che le malattie infettive siano tra le cause. Per facilitare l’accesso all’assistenza sanitaria, IMAM Response and Relief Team (IMARET) fornisce loro una clinica mensile gratuita. L’obiettivo di questo studio è determinare la proporzione di malattie infettive e l’adeguatezza dell’uso di antimicrobici tra i suoi pazienti pediatrici. È stato condotto nel 2017, tramite campionamento universale.

Le informazioni recuperate sono state ottenute tramite interviste e cartelle cliniche. La maggior parte delle diagnosi erano malattie infettive (57,1%), che includono infezioni respiratorie (77,3%), pelle (13,6%), infezioni gastrointestinali (4,5%), occhi e orecchie (entrambe 1%). L’albendazolo (40,7%) era il più prescritto. Solo al 7,4% sono stati prescritti antimicrobici in modo appropriato. L’età (p = 0,005) e il BMI (p = 0,006) erano significativamente associati alle infezioni.

Single Donor Human Pediatric Plasma

IPLASPED11141 each
EUR 253
Description: Single Donor Human Pediatric Plasma

Single Donor Human Pediatric Plasma

IPLASPED11145 each
EUR 1176
Description: Single Donor Human Pediatric Plasma

Single Donor Human Pediatric Plasma

IPLASPED15171 each
EUR 253
Description: Single Donor Human Pediatric Plasma

Single Donor Human Pediatric Plasma

IPLASPED15175 each
EUR 1176
Description: Single Donor Human Pediatric Plasma

Single Donor Human Pediatric Plasma

IPLASPED461 each
EUR 253
Description: Single Donor Human Pediatric Plasma

Single Donor Human Pediatric Plasma

IPLASPED465 each
EUR 1176
Description: Single Donor Human Pediatric Plasma

Single Donor Human Pediatric Plasma

IPLASPED7101 each
EUR 253
Description: Single Donor Human Pediatric Plasma

Single Donor Human Pediatric Plasma

IPLASPED7105 each
EUR 1176
Description: Single Donor Human Pediatric Plasma

Single Donor Human Pediatric SARS-Cov-2 Positive Plasma

IPLASPEDCOV2P100UL each
EUR 127
Description: Single Donor Human Pediatric SARS-Cov-2 Positive Plasma

Adapter Pediatric-tubes - PK6

CEN0173 PK6
EUR 147.15

RealScreen Pediatric FSH ELISA Kit

EL103-096 96T
EUR 2198.4

Single Donor Human Pediatric Serum

ISERSPED031 each
EUR 269
Description: Single Donor Human Pediatric Serum

Single Donor Human Pediatric Serum

ISERSPED035 each
EUR 1268
Description: Single Donor Human Pediatric Serum

Single Donor Human Pediatric Serum

ISERSPED11141 each
EUR 269
Description: Single Donor Human Pediatric Serum

Single Donor Human Pediatric Serum

ISERSPED11145 each
EUR 1268
Description: Single Donor Human Pediatric Serum

Single Donor Human Pediatric Serum

ISERSPED15171 each
EUR 269
Description: Single Donor Human Pediatric Serum

Single Donor Human Pediatric Serum

ISERSPED15175 each
EUR 1268
Description: Single Donor Human Pediatric Serum

Single Donor Human Pediatric Serum

ISERSPED460 each
EUR 269
Description: Single Donor Human Pediatric Serum

Single Donor Human Pediatric Serum

ISERSPED465 each
EUR 1268
Description: Single Donor Human Pediatric Serum

Single Donor Human Pediatric Serum

ISERSPED7101 each
EUR 269
Description: Single Donor Human Pediatric Serum

Single Donor Human Pediatric Serum

ISERSPED7105 each
EUR 1268
Description: Single Donor Human Pediatric Serum

Single Donor Pediatric Human Urine

IRHUSUREPED10131 each
EUR 322
Description: Single Donor Pediatric Human Urine

Single Donor Pediatric Human Urine

IRHUSUREPED10135 each
EUR 1526
Description: Single Donor Pediatric Human Urine

Single Donor Pediatric Human Urine

IRHUSUREPED141 each
EUR 322
Description: Single Donor Pediatric Human Urine

Single Donor Pediatric Human Urine

IRHUSUREPED14171 each
EUR 322
Description: Single Donor Pediatric Human Urine

Single Donor Pediatric Human Urine

IRHUSUREPED14175 each
EUR 1526
Description: Single Donor Pediatric Human Urine

Single Donor Pediatric Human Urine

IRHUSUREPED145 each
EUR 1526
Description: Single Donor Pediatric Human Urine

Single Donor Pediatric Human Urine

IRHUSUREPED591 each
EUR 322
Description: Single Donor Pediatric Human Urine

Single Donor Pediatric Human Urine

IRHUSUREPED595 each
EUR 1526
Description: Single Donor Pediatric Human Urine

Single Donor Human Pediatric Saliva

IRHUSSLPED10171 each
EUR 181
Description: Single Donor Human Pediatric Saliva

Single Donor Human Pediatric Saliva

IRHUSSLPED10175 each
EUR 866
Description: Single Donor Human Pediatric Saliva

Single Donor Human Pediatric Saliva

IRHUSSLPED391 each
EUR 181
Description: Single Donor Human Pediatric Saliva

Single Donor Human Pediatric Saliva

IRHUSSLPED395 each
EUR 866
Description: Single Donor Human Pediatric Saliva

Single Donor Human Pediatric Whole Blood

IWB1SPED031 each
EUR 322
Description: Single Donor Human Pediatric Whole Blood

Single Donor Human Pediatric Whole Blood

IWB1SPED035 each
EUR 1453
Description: Single Donor Human Pediatric Whole Blood

Single Donor Human Pediatric Whole Blood

IWB1SPED11141 each
EUR 322
Description: Single Donor Human Pediatric Whole Blood

Single Donor Human Pediatric Whole Blood

IWB1SPED11145 each
EUR 1453
Description: Single Donor Human Pediatric Whole Blood

Single Donor Human Pediatric Whole Blood

IWB1SPED15171 each
EUR 322
Description: Single Donor Human Pediatric Whole Blood

Single Donor Human Pediatric Whole Blood

IWB1SPED15175 each
EUR 1453
Description: Single Donor Human Pediatric Whole Blood

Single Donor Human Pediatric Whole Blood

IWB1SPED461 each
EUR 322
Description: Single Donor Human Pediatric Whole Blood

Single Donor Human Pediatric Whole Blood

IWB1SPED465 each
EUR 1453
Description: Single Donor Human Pediatric Whole Blood

Single Donor Human Pediatric Whole Blood

IWB1SPED7101 each
EUR 322
Description: Single Donor Human Pediatric Whole Blood

Single Donor Human Pediatric Whole Blood

IWB1SPED7105 each
EUR 1453
Description: Single Donor Human Pediatric Whole Blood

Single Donor Human Pediatric Fecal Matter

IRHUSFMPED03 each
EUR 536
Description: Single Donor Human Pediatric Fecal Matter

Single Donor Human Pediatric Fecal Matter

IRHUSFMPED1114 each
EUR 536
Description: Single Donor Human Pediatric Fecal Matter

Single Donor Human Pediatric Fecal Matter

IRHUSFMPED1517 each
EUR 536
Description: Single Donor Human Pediatric Fecal Matter

Single Donor Human Pediatric Fecal Matter

IRHUSFMPED46 each
EUR 536
Description: Single Donor Human Pediatric Fecal Matter

Single Donor Human Pediatric Fecal Matter

IRHUSFMPED710 each
EUR 536
Description: Single Donor Human Pediatric Fecal Matter

Human Pediatric Peripheral Blood Mononuclear Cells

ABC-TC4351 1 vial Ask for price
Description: Included Diagnoses: Normal, Asthma, Crohn's Disease, IBD, Ulcerative Colitis, Type I Diabetes.

Single Donor Human Pediatric SARS-Cov-2 Positive Serum

ISERSPEDCOV2P100UL each
EUR 127
Description: Single Donor Human Pediatric SARS-Cov-2 Positive Serum

Pediatric malignant tumor tissue array with normal tissue as control

PC701 each
EUR 306
Description: Pediatric malignant tumor tissue array with normal tissue as control, 70 cases/ 70 cores

Stomach cancer with matched adjacent normal tissue array (age<35 years old)

ST8018 each
EUR 306
Description: Stomach cancer with matched adjacent normal tissue array (age<35 years old), including WHO grade, Borrmann grade and Lauren type, 40 cases/80 cores

Plasma Sample Diluent (Antigen-Down SD)

694 100 mL
EUR 57.25

Plasma Sample Diluent (Antigen-Down SD)

695 500 mL
EUR 227.5

Plasma Sample Diluent (Antigen-Down)-SD2

KF17353 500 ml
EUR 338.4

Recent Years Collection Samples. Multiple ovarian tumor tissue array

OV401sur each
EUR 416
Description: Recent Years Collection Samples. Multiple ovarian tumor tissue array, including survival data, pathology grade, TNM and clinical stage (AJCC 8.0), 20 cases/40 cores (1.5mm)

ANTIGEN DOWN PLASMA SAMPLE DILUENT Reagent

GWB-Q00209 100 ml Ask for price

ANTIGEN DOWN PLASMA SAMPLE DILUENT Reagent

GWB-Q00210 1000 ml Ask for price

Sample, Antibody and Conjugate Diluent (20X) for ELISA (For serum, plasma sample conservation and low background)

80066 50 ml
EUR 278.4

OOSA09671-1L - ANTIGEN DOWN PLASMA SAMPLE DILUENT Accessory Reagent

OOSA09671-1L 1000ml
EUR 669

OOSA11219-100ML - ANTIGEN DOWN PLASMA SAMPLE DILUENT Accessory Reagent

OOSA11219-100ML 100ml
EUR 169

NS/0 Sample Diluent

F223A 1000 ml
EUR 1002
Description: NS/0 Sample Diluent by Cygnus Technologies is available in Europe via Gentaur.

NS/0 Sample Diluent

F223A-100 100 ml
EUR 308.4
Description: NS/0 Sample Diluent by Cygnus Technologies is available in Europe via Gentaur.

NS/0 Sample Diluent

F223A-500 500 ml
EUR 585.6
Description: NS/0 Sample Diluent by Cygnus Technologies is available in Europe via Gentaur.

Non-small cell lung cancer NSCLC tissue array (all samples are from recent 4 years) with multiple IHC markers (PD-L1

LC1461 each
EUR 552
Description: Non-small cell lung cancer NSCLC tissue array (all samples are from recent 4 years) with multiple IHC markers (PD-L1, ALK, ROS1+, CD70, HLA1, MPO, CD3 and CD8, containing stained intensity, location and cell type), including pathology grade, TNM and clinical stage, 73 cases/146 cores

SP2/0 Sample Diluent

F183A 1000 ml
EUR 1002
Description: SP2/0 Sample Diluent by Cygnus Technologies is available in Europe via Gentaur.

SP2/0 Sample Diluent

F183A-100 100 ml
EUR 308.4
Description: SP2/0 Sample Diluent by Cygnus Technologies is available in Europe via Gentaur.

SP2/0 Sample Diluent

F183A-500 500 ml
EUR 585.6
Description: SP2/0 Sample Diluent by Cygnus Technologies is available in Europe via Gentaur.

Low Sample Volume Mouse Plasma Protease C1 Inhibitor / C1INH (SERPING1) ELISA Kit

abx352615-96tests 96 tests
EUR 750

Exosome isolation Solution - Serum/ Plasma (easy version of P101, 95% pure exosome) sample

P101EZ--sample - Ask for price

FAME Calib Sample 0% acc ASTM D7806 - 250ML

REFAMECAL0V2 250ML
EUR 95.47

2019-nCoV IgG/IgM RapiCard InstaTest for Whole Blood/Serum/Plasma samples

GEN-176552-25tests 25 tests
EUR 331.2
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus.

2019-nCoV IgG/IgM RapiCard InstaTest for Whole Blood/Serum/Plasma samples

GEN-176552-50tests 50 tests
EUR 566.4
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus.

All Sample Diluents Sample Pack

KF17355 3X100 ml
EUR 326.4

AXYPREP MAG PLASMID KIT- SMALL - 10PREPS- (SAMPLE SIZE)

MAG-P-10 1/pk
EUR 104.4
Description: Bioscience Mag Beads; Magnetic Plasmid

GELLING AGENT SAMPLE PACK

G3500 1EA
EUR 17.71

Plasmid DNA Extraction Mini Kit (Automatic Machine) Sample

FAPDE-AUTO-024 24 preps
EUR 31.5

Sterile Sample Container for sample coll

PW016T-1X100NO 1 unit
EUR 18.77
Description: Sterile Sample Container for sample coll

Sample Treatment Plate

F402 1x 96 wells plate
EUR 123.6
Description: Sample Treatment Plate by Cygnus Technologies is available in Europe via Gentaur.

S-adenosylmethionine ELISA kit for plasma, serum, or tissue/cell homogenate samples

IK00201s 96 tests
EUR 699
Description: S-adenosylmethionine ELISA kit for plasma, serum, or tissue/cell homogenate samples

S-adenosylhomocysteine ELISA kit for plasma, serum, or tissue/cell homogenate samples

IK00301s 96 tests
EUR 1349
Description: S-adenosylhomocysteine ELISA kit for plasma, serum, or tissue/cell homogenate samples

pBI121 old Plasmid

PVT3002 2 ug
EUR 444

Eye Lysate (0 Days Old)

1420-0 0.1 mg
EUR 229.2
Description: Eye tissue lysate (0 Days Old) was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Lung Lysate (0 Days Old)

1402-0 0.1 mg
EUR 229.2
Description: Lung tissue lysate (0 Days Old) was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Skin Lysate (0 Days Old)

1419-0 0.1 mg
EUR 229.2
Description: Skin tissue lysate (0 Days Old) was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Brain Lysate (0 Days Old)

1403-0 0.1 mg
EUR 229.2
Description: Brain tissue lysate (0 Days Old) was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Liver Lysate (0 Days Old)

1404-0 0.1 mg
EUR 229.2
Description: Liver tissue lysate (0 Days Old) was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Kidney Lysate (0 Days Old)

1405-0 0.1 mg
EUR 229.2
Description: Kidney tissue lysate (0 Days Old) was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Stomach Lysate (0 Day Old)

1415-0 0.1 mg
EUR 229.2
Description: Stomach tissue lysate (0 Day Old) was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Sample Diluent

I094 1000 ml
EUR 622.8
Description: Sample Diluent by Cygnus Technologies is available in Europe via Gentaur.

Sample Diluent

I094-100 100 ml
EUR 253.2
Description: Sample Diluent by Cygnus Technologies is available in Europe via Gentaur.

Sample Diluent

I094-500 500 ml
EUR 447.6
Description: Sample Diluent by Cygnus Technologies is available in Europe via Gentaur.

Sample Diluent

E-ELIR-011-24Tests 24 Tests Ask for price

Sample Diluent

E-ELIR-011-48Tests 48 Tests
EUR 100

Sample Diluent

E-ELIR-011-96Tests 96 Tests
EUR 20

Sample Diluent

E-ELIR-011-96Tests10 96 Tests *10
EUR 200

Sample Diluent

E-ELIR-011-96Tests5 96 Tests *5
EUR 100

3 Blocking Buffer Sample Pack

KF17340 3 x 100 ml
EUR 246

S-adenosylmethionine ELISA kit for plasma, serum, or tissue/cell homogenate samples, broad range

IK00202s 96 tests
EUR 749
Description: S-adenosylmethionine ELISA kit for plasma, serum, or tissue/cell homogenate samples, broad range

S-adenosylmethionine ELISA kit for plasma, serum, or tissue/cell homogenate samples, broad range

IK00203s 48 tests
EUR 449
Description: S-adenosylmethionine ELISA kit for plasma, serum, or tissue/cell homogenate samples, broad range

S-adenosylhomocysteine ELISA kit for plasma, serum, or tissue/cell homogenate samples, broad range

IK00302s 96 tests
EUR 1399
Description: S-adenosylhomocysteine ELISA kit for plasma, serum, or tissue/cell homogenate samples, broad range

Sample of P201

P201S 2 rxn
EUR 69

Human IgG-RF stripper/Adsorbent (1 ml, sufficient for stripping 50 samples of 100 ul human serum/plasma)

RFS-1 1 ml
EUR 123.6

Sample Reducing Agent for Protein PAGE 10X

21440022-1 5 mL
EUR 15.66

Sample Reducing Agent for Protein PAGE 10X

21440022-2 10 mL
EUR 25.75

Sample Reducing Agent for Protein PAGE 10X

21440022-3 25 mL
EUR 42.35

PTcon SAMPLE PACK

C2125 5EA
EUR 32.34

TUNAIR SAMPLE KIT

SS-7001 -
EUR 248.44

BSA Sample Diluent

F031A 1000 ml
EUR 585.6
Description: BSA Sample Diluent by Cygnus Technologies is available in Europe via Gentaur.

BSA Sample Diluent

F031A-100 100 ml
EUR 234
Description: BSA Sample Diluent by Cygnus Technologies is available in Europe via Gentaur.

BSA Sample Diluent

F031A-500 500 ml
EUR 493.2
Description: BSA Sample Diluent by Cygnus Technologies is available in Europe via Gentaur.

DNA Sample Diluent

D006-100 100 ml
EUR 447.6
Description: DNA Sample Diluent by Cygnus Technologies is available in Europe via Gentaur.

DNA Sample Diluent

D006-1000 1000 ml
EUR 1400.4
Description: DNA Sample Diluent by Cygnus Technologies is available in Europe via Gentaur.

DNA Sample Diluent

D006-500 500 ml
EUR 871.2
Description: DNA Sample Diluent by Cygnus Technologies is available in Europe via Gentaur.

IgM Sample Diluent

MD-4 each
EUR 80

RSV Positive Sample

DAG-H10378 1 ml dry ice
EUR 1326

Sample Diluent, 60ML

X028-60ML 60ML
EUR 109

Sample Diluent, 100ML

X145-100ML 100ML
EUR 112

ELISA Sample Diluent

ESD125 125 ml
EUR 24.43

ELISA Sample Diluent

ESD500 500 ml
EUR 47.58

ELISA Sample Diluent

ESD999 1000 ml
EUR 86.15

HEPES Sample Diluent

I050 1000 ml
EUR 632.4
Description: HEPES Sample Diluent by Cygnus Technologies is available in Europe via Gentaur.

HEPES Sample Diluent

I050-100 100 ml
EUR 262.8
Description: HEPES Sample Diluent by Cygnus Technologies is available in Europe via Gentaur.

HEPES Sample Diluent

I050-500 500 ml
EUR 400.8
Description: HEPES Sample Diluent by Cygnus Technologies is available in Europe via Gentaur.

Sample diluent bufer

AR1106-1 30ml
EUR 150
Description: ELISA

Sample Diluent Buffer

abx296001-20ml 20 ml
EUR 109.2

CytoCiteâ„¢ Sample Tube

CCT100 500 Tubes
EUR 88
Description: Cytocite™ sample tubes are 500 uL thin-walled polypropylene tubes validated for use with Cytocite or Qubit Fluorometer.

CytoCiteâ„¢ Sample Tube

CCT100-500Tubes 500 Tubes
EUR 86
Description: Cytocite™ sample tubes are 500 uL thin-walled polypropylene tubes validated for use with Cytocite or Qubit Fluorometer.

Sample Diluent Buffer

I028-100 100 ml
EUR 253.2
Description: Sample Diluent Buffer by Cygnus Technologies is available in Europe via Gentaur.

Sample Diluent Buffer

I028-1000 1000 ml
EUR 622.8
Description: Sample Diluent Buffer by Cygnus Technologies is available in Europe via Gentaur.

Sample Diluent Buffer

I028-500 500 ml
EUR 447.6
Description: Sample Diluent Buffer by Cygnus Technologies is available in Europe via Gentaur.

Zymogram Sample Buffer

40120378-1 25 ml
EUR 21.7

Zymogram Sample Buffer

40120378-2 50 ml
EUR 35.33

Sample Dilution Buffer

STKC10 100mL
EUR 55

Heart Lysate (0 day old mouse)

1401-0 0.1 mg
EUR 229.2
Description: Heart tissue lysate (0 day old mouse) was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Sample Treatment Buffer

F175 1000 ml
EUR 493.2
Description: Sample Treatment Buffer by Cygnus Technologies is available in Europe via Gentaur.

Sample Treatment Buffer

F175-100 100 ml
EUR 262.8
Description: Sample Treatment Buffer by Cygnus Technologies is available in Europe via Gentaur.

comb 10 sample, 0.8mm

EVS3100-C10-0.8 ea
EUR 70.8

comb 10 sample, 1.5mm

EVS3100-C10-1.5 ea
EUR 70.8

comb 12 sample, 0.8mm

EVS3100-C12-0.8 ea
EUR 70.8

comb 12 sample, 1.5mm

EVS3100-C12-1.5 ea
EUR 70.8

comb 6 sample, 0.8mm

EVS3100-C6-0.8 ea
EUR 70.8

comb 6 sample, 1.5mm

EVS3100-C6-1.5 ea
EUR 70.8

comb 8 sample, 0.8mm

EVS3100-C8-0.8 ea
EUR 70.8

comb 8 sample, 1.5mm

EVS3100-C8-1.5 ea
EUR 70.8

Per valutare, in un contesto ambulatoriale, se un punteggio CASI predice accuratamente la gravità / il controllo dell’asma come determinato tramite la valutazione subspecialista. I punteggi del test di controllo dell’asma (ACT) e dei punteggi ACT (C-ACT) dell’infanzia sono stati generati per fornire un contesto aggiuntivo per i punteggi CASI in relazione alle valutazioni utilizzando un altro strumento clinico.